Table Of Contents

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Product Type

  2.3.2 Market Size By Guidance Technique

  2.3.3 Market Size By Application

  2.3.4 Market Size By End User

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

     4.1 Adoption & Usage Metrics

4.1.1 Percentage (%) of hospitals and diagnostic centres using needle-based vs. vacuum-assisted biopsy devices

4.1.2 Average number of biopsy procedures performed per device annually

4.1.3 Adoption rate (%) of image-guided systems (ultrasound, MRI, CT) in oncology diagnostics

4.1.4 Percentage (%) of procedures relying on minimally invasive vs. traditional biopsy techniques

4.1.5 Growth (%) in adoption for precision-guided and AI-assisted biopsy systems

      4.2 Operational & Performance Metrics

4.2.1 Average procedure time (minutes) for different biopsy device types

4.2.2 Tissue sampling accuracy (%) across various device models

4.2.3 Device reliability metrics: mean time between failures (MTBF) and downtime in clinical use

4.2.4 Patient safety metrics: complication rates (bleeding, infection) per 1,000 procedures

4.2.5 Utilization rates of disposable accessories (needles, cannulas) and their impact on efficiency

     4.3 Technology & Innovation Metrics

4.3.1 Adoption (%) of integrated imaging and real-time guidance systems

4.3.2 Growth (%) in vacuum-assisted and MRI-compatible biopsy device development

4.3.3 Trends in miniaturization for paediatric and minimally invasive applications

4.3.4 Share (%) of devices featuring automated sampling and safety adjustment systems

4.3.5 Innovations in tissue preservation, sample integrity, and reduced patient trauma

     4.4 End-Use & Market Insights

4.4.1 Regional trends in biopsy adoption rates (North America vs. Asia-Pacific vs. Europe)

4.4.2 Preference trends: hospitals vs. diagnostic & imaging centres for device types

4.4.3 Impact of rising breast and prostate cancer screening programs on device demand

4.4.5 Increasing demand from specialty oncology clinics and transplant centers for precision-guided devices.

5. Biopsy Devices Market Segmental Analysis & Forecast, By Product Type, 2022 – 2035, Value (USD Billion)

5.1 Introduction

 5.2 Needle Based Biopsy Guns

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022 – 2035

 5.3 Biopsy Guidance System

 5.4 Biopsy Needles

     5.5 Biopsy Forceps

     5.6 Others

6. Biopsy Devices Market Segmental Analysis & Forecast, By Guidance Technique, 2022 – 2035, Value (USD Billion)

    6.1 Introduction

 6.2 Ultrasound-Guided Biopsy

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022 – 2035

     6.3 MRI-Guided Biopsy

     6.4 CT-Guided Biopsy

     6.5 Stereotactic-Guided Biopsy

     6.6 Others

7. Biopsy Devices Market Segmental Analysis & Forecast, By Application, 2022 – 2035, Value (USD Billion)

    7.1 Introduction

 7.2 Breast Biopsy

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022 – 2035

 7.3 Prostate Biopsy

     7.4 Lung Biopsy

     7.5 Others

8. Biopsy Devices Market Segmental Analysis & Forecast, By End-User, 2022 – 2035, Value (USD Billion)

    8.1 Introduction

 8.2 Hospitals & Clinics

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022 – 2035

     8.3 Diagnostics & Imaging Centers

     8.4 Academic & Research Institutes

     8.5 Others

9. Biopsy Devices Market Segmental Analysis & Forecast By Region, 2022 – 2035, Value (USD Billion)

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 Biopsy Devices Market Size & Forecast, By Product Type, 2022 – 2035

 9.2.3 Biopsy Devices Market Size & Forecast, By Guidance Technique, 2022 – 2035

 9.2.4 Biopsy Devices Market Size & Forecast, By Application, 2022 – 2035

 9.2.5 Biopsy Devices Market Size & Forecast, By End-User, 2022 – 2035

 9.2.6 Biopsy Devices Market Size & Forecast, By Country, 2022 – 2035

  9.2.6.1 USA

  9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Biopsy Devices Market Size & Forecast, By Product Type, 2022 – 2035

 9.3.3 Biopsy Devices Market Size & Forecast, By Guidance Technique, 2022 – 2035

 9.3.4 Biopsy Devices Market Size & Forecast, By Application, 2022 – 2035

 9.3.5 Biopsy Devices Market Size & Forecast, By End-User, 2022 – 2035

 9.3.6 Biopsy Devices Market Size & Forecast, By Country, 2022 – 2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Biopsy Devices Market Size & Forecast, By Product Type, 2022 – 2035

 9.4.3 Biopsy Devices Market Size & Forecast, By Guidance Technique, 2022 – 2035

 9.4.4 Biopsy Devices Market Size & Forecast, By Application, 2022 – 2035

 9.4.5 Biopsy Devices Market Size & Forecast, By End-User, 2022 – 2035

 9.4.6 Biopsy Devices Market Size & Forecast, By Country, 2022 – 2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Biopsy Devices Market Size & Forecast, By Product Type, 2022 – 2035

 9.5.3 Biopsy Devices Market Size & Forecast, By Guidance Technique, 2022 – 2035

 9.5.4 Biopsy Devices Market Size & Forecast, By Application, 2022 – 2035

 9.5.5 Biopsy Devices Market Size & Forecast, By End-User, 2022 – 2035

 9.5.6 Biopsy Devices Market Size & Forecast, By Country, 2022 – 2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Biopsy Devices Market Size & Forecast, By Product Type, 2022 – 2035

 9.6.3 Biopsy Devices Market Size & Forecast, By Guidance Technique, 2022 – 2035

 9.6.4 Biopsy Devices Market Size & Forecast, By Application, 2022 – 2035

 9.6.5 Biopsy Devices Market Size & Forecast, By End-User, 2022 – 2035

 9.6.6 Biopsy Devices Market Size & Forecast, By Country, 2022 – 2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 Egypt

  9.6.6.5 South Africa

  9.6.6.6 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Key Strategies Adopted (%), By Key Players, 2025

  10.2.2 Year-Wise Strategies & Development, 2022 – 2025

  10.2.3 Number Of Strategies Adopted By Key Players, 2025

 10.3 Market Share Analysis, 2025

 10.4 Product/Service & Network Type Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Network Type Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

10.6.1 Hologic, Inc.

  10.6.1.1 Company Overview & Snapshot

  10.6.1.2 Product/Service Portfolio

  10.6.1.3 Key Company Financials

  10.6.1.4 SWOT Analysis

10.6.2 Becton, Dickinson and Company (BD) 

10.6.3 Cook Group Incorporated 

10.6.4 Argon Medical Devices 

10.6.5 Boston Scientific Corporation 

10.6.6 Gallini Medical 

10.6.7 TSK Laboratory Europe 

10.6.8 B. Braun Melsungen AG 

10.6.9 Cardinal Health, Inc. 

10.6.10 Medtronic plc 

10.6.11 FUJIFILM Holdings Corporation 

10.6.12 INRAD Inc. 

10.6.13 Olympus Corporation 

10.6.14 Merit Medical Systems, Inc. 

10.6.15 IZI Medical Products 

10.6.16 Danaher Corporation 

10.6.17 Devicor Medical Products (part of Leica Biosystems/Danaher) 

10.6.18 C.R. Bard (now part of BD) 

10.6.19 Stryker Corporation 

10.6.20 Siemens Healthineers

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions on Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List of Tables

 14.2 List of Figures